Soh Saitoh

Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis.

Yukio Ando, Hideo Saka, Maki Ando et al. · PubMed · 2000 · 788 citations

Medicine, Genetics, Pharmacology +15

Phase II study of oral S‐1 for treatment of metastatic colorectal carcinoma

Kuniaki Shirao, Atsushi Ohtsu, Hideho Takada et al. · Cancer · 2004 · 116 citations · Full text

Medicine, Oncology, Pharmacology +14

Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability

Yasuyuki Miyakura, Kokichi Sugano, Takayuki Akasu et al. · Clinical Gastroenterology and Hepatology · 2004 · 116 citations

Life Sciences, Genetics, Oncology +17

Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer

Taroh Satoh, Kyung Hee Lee, Sun Young Rha et al. · Gastric Cancer · 2014 · 115 citations · Full text

Medicine, Oncology, Pharmacology +16

Pattern of p53 Gene Mutations in Breast Cancers of Women of the Midwestern United States

Steve S. Sommer, J. M. Cunningham, R. M. McGovern et al. · JNCI Journal of the National Cancer Institute · 1992 · 93 citations

Medicine, Genetics, Oncology +13